Mounjaro (tirzepatide) is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus in adults
A BMI of 27 or higher if you're also dealing with at least one weight-related health issue, like high blood pressure, type 2 diabetes, or high cholesterol
Comparing the Chemical Designs of Semaglutide, Tirzepatide, and Retatrutide Peptides often face poor pharmacokinetics, making them susceptible to enzymatic degradation, renal clearance, and rapid receptor-mediated clearance
Healthy fats: Avocados, nuts, olive oil and foods rich in dietary fats encourage balanced blood sugar and aid GLP-1 activation
They are NOT recommended for individuals with: Ulcerative colitis, Crohns disease, or active GI inflammation Severe hemorrhoids Heart arrhythmias or uncontrolled hypertension Pregnancy Kidney disease (electrolyte shifts can be dangerous) Caffeine sensitivity Always consult a licensed provider if you have chronic conditions or are following a detox program
